Latest Development Program News

Hydrix Limited’s subsidiary has landed a significant A$2.5 million contract to develop SynCardia’s next-generation fully implantable Total Artificial Heart, marking a major step in advanced cardiovascular technology.

Adisyn Ltd has successfully demonstrated low-temperature deposition of an sp²-based carbon layer using Atomic Layer Deposition, a milestone independently verified and critical for semiconductor integration.

AnteoTech secures a significant order from the Serum Institute of India and expands its Life Sciences pipeline with new product developments and global partnerships, positioning for accelerated growth in 2026.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.

Kalamazoo Resources has raised $8 million through a placement and launched a $2 million share purchase plan, aiming to fuel exploration and development across its gold projects.

Racura Oncology has appointed Beyond Drug Development to oversee its HARNESS-1 Phase 1a/b trial combining RC220 with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward clinical advancement.

InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.

Pearl Gull Iron has completed the sale of its Cockatoo Island Project, receiving $4.5 million in cash, a 4% indirect stake in Crestlink Pty Ltd, and ongoing royalties. The transaction positions the company to pursue new growth opportunities while maintaining exposure to the project’s future upside.

Aurum Resources reports multiple high-grade gold intercepts at its 2.41Moz Boundiali Gold Project in Côte d’Ivoire, expanding resource confidence and scale. The company boosts drilling capacity to 12 rigs, targeting major resource updates and a Pre-Feasibility Study in early 2026.

Amaero Ltd has secured a A$4.6 million order from Titomic under their exclusive five-year agreement, marking a significant step in supplying critical refractory and titanium powders for defense applications.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.